Tocqueville Asset Management L.P. lessened its stake in shares of Colgate-Palmolive (NYSE:CL) by 19.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 320,085 shares of the company’s stock after selling 76,295 shares during the quarter. Tocqueville Asset Management L.P.’s holdings in Colgate-Palmolive were worth $22,035,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in CL. Nuveen Asset Management LLC boosted its position in shares of Colgate-Palmolive by 16,117.1% during the 2nd quarter. Nuveen Asset Management LLC now owns 6,435,107 shares of the company’s stock worth $461,204,000 after purchasing an additional 6,395,426 shares in the last quarter. Invesco Ltd. boosted its position in shares of Colgate-Palmolive by 201.8% during the 2nd quarter. Invesco Ltd. now owns 8,642,044 shares of the company’s stock worth $619,374,000 after purchasing an additional 5,778,145 shares in the last quarter. AQR Capital Management LLC boosted its position in shares of Colgate-Palmolive by 52.2% during the 2nd quarter. AQR Capital Management LLC now owns 3,485,442 shares of the company’s stock worth $249,801,000 after purchasing an additional 1,195,074 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Colgate-Palmolive by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 76,502,840 shares of the company’s stock worth $5,482,958,000 after purchasing an additional 1,056,530 shares in the last quarter. Finally, Natixis boosted its position in shares of Colgate-Palmolive by 504.3% during the 2nd quarter. Natixis now owns 1,009,727 shares of the company’s stock worth $72,367,000 after purchasing an additional 842,644 shares in the last quarter. 76.69% of the stock is currently owned by institutional investors.

NYSE CL traded up $0.15 during trading hours on Tuesday, hitting $70.29. The company’s stock had a trading volume of 4,711,929 shares, compared to its average volume of 4,163,094. Colgate-Palmolive has a 52 week low of $60.96 and a 52 week high of $76.41. The company has a market capitalization of $60.12 billion, a PE ratio of 23.67, a price-to-earnings-growth ratio of 5.43 and a beta of 0.71. The company has a current ratio of 1.03, a quick ratio of 0.70 and a debt-to-equity ratio of 43.94. The company’s 50-day simple moving average is $68.44 and its two-hundred day simple moving average is $70.37.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, November 1st. The company reported $0.71 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.70 by $0.01. Colgate-Palmolive had a net margin of 15.04% and a return on equity of 6,492.71%. The business had revenue of $3.93 billion for the quarter, compared to analysts’ expectations of $3.95 billion. During the same quarter last year, the firm earned $0.72 EPS. The firm’s revenue for the quarter was up 2.2% compared to the same quarter last year. Research analysts anticipate that Colgate-Palmolive will post 2.83 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Thursday, January 23rd will be paid a $0.43 dividend. The ex-dividend date is Wednesday, January 22nd. This represents a $1.72 annualized dividend and a yield of 2.45%. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.91%.

CL has been the topic of a number of research analyst reports. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $70.00 price objective on the stock. in a research report on Monday, November 4th. Morgan Stanley set a $71.00 price target on shares of Colgate-Palmolive and gave the company a “hold” rating in a research report on Monday, November 4th. Deutsche Bank raised their price target on shares of Colgate-Palmolive from $72.00 to $73.00 and gave the company a “hold” rating in a research report on Thursday, December 12th. Bank of America cut shares of Colgate-Palmolive from a “buy” rating to a “neutral” rating and dropped their price target for the company from $77.00 to $74.00 in a research report on Thursday, December 19th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Colgate-Palmolive from $78.00 to $76.00 and set a “neutral” rating on the stock in a research report on Monday, October 14th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $72.85.

In other Colgate-Palmolive news, Chairman Ian M. Cook sold 17,750 shares of the stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $68.30, for a total value of $1,212,325.00. Following the completion of the sale, the chairman now owns 995,075 shares in the company, valued at approximately $67,963,622.50. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Chairman Ian M. Cook sold 16,000 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $66.70, for a total transaction of $1,067,200.00. Following the completion of the sale, the chairman now owns 1,099,361 shares of the company’s stock, valued at approximately $73,327,378.70. The disclosure for this sale can be found here. In the last quarter, insiders sold 67,500 shares of company stock valued at $4,569,293. Company insiders own 1.14% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

See Also: What is Cost of Goods Sold (COGS)?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.